Elite Pharmaceuticals, Inc. Estimated Litigation Liability, Current
Elite Pharmaceuticals, Inc. (ELTP) had Estimated Litigation Liability, Current of $174.22 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LitigationReserveCurrent · last filed 2026-08-13
- 2026-06-30: Estimated Litigation Liability, Current $174.22K.
- 2026-03-31: Estimated Litigation Liability, Current $282.67K.
- 2025-12-31: Estimated Litigation Liability, Current $394.57K.
- 2025-09-30: Estimated Litigation Liability, Current $279.01K.
| Period end | Estimated Litigation Liability, Current |
|---|---|
| 2026-06-30 | $174.22K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $282.67K 10-Q · filed 2026-08-13 |
| 2025-12-31 | $394.57K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $279.01K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $610.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $55.00K 10-K · filed 2026-06-29 |
| 2024-12-31 | $73.51K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $125.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $165.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $90.00K 10-K · filed 2025-06-30 |
| 2023-12-31 | $75.00K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $70.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $90.00K 10-Q · filed 2023-08-14 |